Cargando…

Editorial: Advances in Immunotherapeutic Approaches to Tuberculosis

Detalles Bibliográficos
Autores principales:	Estrada García, Iris, Hernández Pando, Rogelio, Ivanyi, Juraj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100343/ https://www.ncbi.nlm.nih.gov/pubmed/33968090 http://dx.doi.org/10.3389/fimmu.2021.684200

Ejemplares similares

Function and Potentials of M. tuberculosis Epitopes
por: Ivanyi, Juraj
Publicado: (2014)

Editorial: Complement and Immunotherapeutics
por: Okrój, Marcin, et al.
Publicado: (2021)

Advancing Immunotherapeutic Vaccine Strategies Against Pulmonary Tuberculosis
por: Afkhami, Sam, et al.
Publicado: (2020)

Editorial: Glycoconjugates in vaccines and immunotherapeutics
por: Shivatare, Sachin, et al.
Publicado: (2022)

Significance of Antigen and Epitope Specificity in Tuberculosis
por: Ivanyi, Juraj, et al.
Publicado: (2014)

Editorial: “AAV Gene Therapy: Immunology and Immunotherapeutics”
por: Martinez-Navio, José M., et al.
Publicado: (2021)

Editorial: Immunotherapeutic and Immunoprophylactic Strategies for Infectious Diseases
por: Sautto, Giuseppe A., et al.
Publicado: (2020)

The Role of Mast Cells in Tuberculosis: Orchestrating Innate Immune Crosstalk?
por: Garcia-Rodriguez, Karen M., et al.
Publicado: (2017)

Editorial: The immune escape mechanism and novel immunotherapeutic strategies of leukemia
por: Yu, Kang, et al.
Publicado: (2023)

Editorial: Understanding Gamma Delta T Cell Multifunctionality - Towards Immunotherapeutic Applications
por: Gustafsson, Kenth, et al.
Publicado: (2020)

Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
por: Li, Wenting, et al.
Publicado: (2023)

Editorial: Unveiling the tumor microenvironment by machine learning to develop new immunotherapeutic strategies
por: Zheng, Ping, et al.
Publicado: (2023)

Thinking Outside the Box: Innate- and B Cell-Memory Responses as Novel Protective Mechanisms Against Tuberculosis
por: Choreño-Parra, José Alberto, et al.
Publicado: (2020)

The Cholinergic System Contributes to the Immunopathological Progression of Experimental Pulmonary Tuberculosis
por: Islas-Weinstein, Leon, et al.
Publicado: (2021)

Biological role of NK cells and immunotherapeutic approaches in breast cancer
por: Roberti, María P., et al.
Publicado: (2012)

CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
por: Morandi, Fabio, et al.
Publicado: (2018)

Immunotherapeutic Potential of Extracellular Vesicles
por: Zhang, Bin, et al.
Publicado: (2014)

Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements
por: Yun, Chae-Ok, et al.
Publicado: (2022)

Immunotherapeutic Effects of Different Doses of Mycobacterium tuberculosis ag85a/b DNA Vaccine Delivered by Electroporation
por: Liang, Yan, et al.
Publicado: (2022)

Editorial: Research advances of tuberculosis vaccine and its implication on COVID-19
por: Gong, Wenping, et al.
Publicado: (2023)

TREX1 as a Novel Immunotherapeutic Target
por: Hemphill, Wayne O., et al.
Publicado: (2021)

NKT Cells as an Ideal Anti-Tumor Immunotherapeutic
por: Fujii, Shin-ichiro, et al.
Publicado: (2013)

Immunotherapeutic progress and application of bispecific antibody in cancer
por: Kang, Jingyue, et al.
Publicado: (2022)

Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches
por: Bottino, Cristina, et al.
Publicado: (2014)

Role of antibodies in vaccine-mediated protection against tuberculosis
por: Dieli, Francesco, et al.
Publicado: (2022)

Mucosal Therapy of Multi-Drug Resistant Tuberculosis With IgA and Interferon-γ
por: Tran, Andy C., et al.
Publicado: (2020)

Editorial: Approaches to Advance Cancer Vaccines to Clinical Utility
por: Van Nuffel, An M. T., et al.
Publicado: (2019)

Advances in Immunotherapeutic Approaches to Type 1 Diabetes
por: Cudini, Annamaria, et al.
Publicado: (2023)

Universal Ready-to-Use Immunotherapeutic Approach for the Treatment of Cancer: Expanded and Activated Polyclonal γδ Memory T Cells
por: Polito, Vinicia A., et al.
Publicado: (2019)

Treg: A Promising Immunotherapeutic Target in Oral Diseases
por: Zhang, Yujing, et al.
Publicado: (2021)

TLR Agonists as Mediators of Trained Immunity: Mechanistic Insight and Immunotherapeutic Potential to Combat Infection
por: Owen, Allison M., et al.
Publicado: (2021)

Immunodiagnosis and Immunotherapeutics Based on Human Papillomavirus for HPV-Induced Cancers
por: Dong, Zhen, et al.
Publicado: (2021)

Antibody diversity in IVIG: Therapeutic opportunities for novel immunotherapeutic drugs
por: von Gunten, Stephan, et al.
Publicado: (2023)

Active tuberculosis patients have high systemic IgG levels and B-cell fingerprinting, characterized by a reduced capacity to produce IFN-γ or IL-10 as a response to M.tb antigens
por: Flores-Gonzalez, Julio, et al.
Publicado: (2023)

Immunotherapeutic Advances for NSCLC
por: Massafra, Marco, et al.
Publicado: (2021)

Immunotherapeutic Advancements for Glioblastoma
por: Ampie, Leonel, et al.
Publicado: (2015)

Evidence for the Effect of Vaccination on Host-Pathogen Interactions in a Murine Model of Pulmonary Tuberculosis by Mycobacterium tuberculosis
por: Zatarain-Barrón, Zyanya Lucia, et al.
Publicado: (2020)

Improving the Outcome of Leukemia by Natural Killer Cell-Based Immunotherapeutic Strategies
por: Chouaib, Salem, et al.
Publicado: (2014)

Diverse Mechanisms Regulate the Surface Expression of Immunotherapeutic Target CTLA-4
por: Schneider, Helga, et al.
Publicado: (2014)

Colorectal Cancer Immune Infiltrates: Significance in Patient Prognosis and Immunotherapeutic Efficacy
por: Guo, Liang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uc7ijriuphot2k603t647qdev3